Exemestane for system suitability

Get a Price/Quote

MOQ : 1 Kilograms

Exemestane for system suitability Specification

Usage
Exemestane is indicated for adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to exemestane for completion of a total of five consecutive years of adjuvant hormonal therapy [see Clinical Studies (14.1)].

Molecular Formula
C20H24O2

Molecular Weight
296.4 Grams (g)

Appearance
Off-White to Pale Green Solid

Melting Point
190-195oC

Exemestane for system suitability Trade Information

Minimum Order Quantity
1 Kilograms

Payment Terms
Cash in Advance (CID), Cash Advance (CA)

Supply Ability
500 Kilograms KG Per Month

Delivery Time
2-8 Week

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
Carton and Poly Bag.

Main Export Market(s)
Australia, Eastern Europe, Central America, Africa, Middle East, South America, Western Europe, Asia, North America

Main Domestic Market
All India

About Exemestane for system suitability

Exemestane for system suitabilityEuropean Pharmacopoeia (EP) Reference StandardSynonym: 6-Methyleneandrosta-1,4-diene-3,17-dione, ExemestaneCAS Number107868-30-4Empirical Formula (Hill Notation)C20H24O2Molecular Weight296.40PropertiesRelated CategoriesAnalytical Standards,Analytical/Chromatography,EP Standards,EP Standards E - F,Pharmacopeia & Metrological Institutes StandardsInChI Key BFYIZQONLCFLEV-DAELLWKTSA-N

FAQs of Exemestane for system suitability:

Q: What is the molecular formula of Exemestane?

A: The molecular formula of Exemestane is C20H24O2.

Q: What is the molecular weight of Exemestane?

A: The molecular weight of Exemestane is 296.4 grams (g).

Q: What is the melting point range of Exemestane?

A: The melting point of Exemestane ranges from 190C to 195C.

Q: What does Exemestane look like?

A: Exemestane appears as an off-white to pale green solid.

Q: What is the usage of Exemestane?

A: Exemestane is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to exemestane for the completion of a total of five consecutive years of adjuvant hormonal therapy.

Tell us about your requirement